BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21399668)

  • 1. Prognostic impact of iron parameters in patients undergoing allo-SCT.
    Bazuaye GN; Buser A; Gerull S; Tichelli A; Stern M
    Bone Marrow Transplant; 2012 Jan; 47(1):60-4. PubMed ID: 21399668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.
    Meyer SC; O'Meara A; Buser AS; Tichelli A; Passweg JR; Stern M
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):440-4. PubMed ID: 23089566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
    Kim YR; Kim JS; Cheong JW; Song JW; Min YH
    Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.
    Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Yağci M
    Transplant Proc; 2010 Jun; 42(5):1841-8. PubMed ID: 20620535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation.
    Altès A; Remacha AF; Sureda A; Martino R; Briones J; Canals C; Brunet S; Sierra J; Gimferrer E
    Bone Marrow Transplant; 2002 Jun; 29(12):987-9. PubMed ID: 12098067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Plasma Endothelin-1, Transforming Growth Factor-β, Fibroblast Growth Factor, and Nitric Oxide Levels and Liver Injury in Hematopoietic Stem Cell Transplantation Recipients with Persistent Iron Overload after Transplantation.
    Akı ŞZ; Suyanı E; Cengiz M; Özenirler S; Elbeğ Ş; Paşaoğlu H; Sucak GT
    Biol Blood Marrow Transplant; 2015 May; 21(5):948-53. PubMed ID: 25681034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Kataoka K; Nannya Y; Hangaishi A; Imai Y; Chiba S; Takahashi T; Kurokawa M
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):195-204. PubMed ID: 19167679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin and iron deficiency in pre-kidney transplant patients.
    Sancho A; Pastor MC; Troya M; Bonal J; Bayés B; Morales-Indiano C; Lauzurica R; Romero R
    Transplant Proc; 2009; 41(6):2079-81. PubMed ID: 19715836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.
    Dadwal SS; Tegtmeier B; Liu X; Frankel P; Ito J; Forman SJ; Pullarkat V
    Eur J Haematol; 2015 Mar; 94(3):235-42. PubMed ID: 25082161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
    Lim ZY; Fiaccadori V; Gandhi S; Hayden J; Kenyon M; Ireland R; Marsh J; Ho AY; Mufti GJ; Pagliuca A
    Leuk Res; 2010 Jun; 34(6):723-7. PubMed ID: 19944463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble transferrin receptors and ferritin in Type 2 diabetic patients.
    Hernández C; Lecube A; Carrera A; Simó R
    Diabet Med; 2005 Jan; 22(1):97-101. PubMed ID: 15606699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis.
    Yeap BB; Divitini ML; Gunton JE; Olynyk JK; Beilby JP; McQuillan B; Hung J; Knuiman MW
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):525-32. PubMed ID: 24953981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved preoperative iron status assessment by soluble transferrin receptor in elderly patients undergoing knee and hip replacement.
    Basora M; Deulofeu R; Salazar F; Quinto L; Gomar C
    Clin Lab Haematol; 2006 Dec; 28(6):370-5. PubMed ID: 17105489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum iron parameters in the early post-transplant period and infection risk in kidney transplant recipients.
    Fernández-Ruiz M; López-Medrano F; Andrés A; Morales JM; Lumbreras C; San-Juan R; Polanco N; González E; Aguado JM
    Transpl Infect Dis; 2013 Dec; 15(6):600-11. PubMed ID: 24011120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron deficiency in the acute-phase reaction after open aortic surgery.
    Solis JV; Portero JL; Diaz J; Garcia R; Ligero JM; Vazquez E; Lodeiro C; Ballesteros L
    Vasc Endovascular Surg; 2006; 40(5):392-8. PubMed ID: 17038573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation.
    Pullarkat V; Blanchard S; Tegtmeier B; Dagis A; Patane K; Ito J; Forman SJ
    Bone Marrow Transplant; 2008 Dec; 42(12):799-805. PubMed ID: 18762767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Credibility of the measurement of serum ferritin and transferrin receptor as indicators of iron deficiency anemia in hemodialysis patients.
    Mahdavi MR; Makhlough A; Kosaryan M; Roshan P
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1158-62. PubMed ID: 22165676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease.
    Marković M; Majkić-Singh N; Subota V
    Scand J Clin Lab Invest; 2005; 65(7):571-6. PubMed ID: 16271988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.